age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
63.15097
|
male
| 1
| 41
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
|
$11-$25k
| 0
| 276,936
| 104,526
| 112,121.75
| 28.75
|
white
| 19.398438
| 28
| 0.855957
| 0.761963
| 3
| 0
| 0
|
no
| 0.5
| 0.25
|
dnr after sadm
| 40
| 98
| 11.699219
| 50
| 20
| 35.5
| null | null | 0.899902
| 1.299805
| 149
| null | 429
| 37
| 2,085
| 5
| 1
|
<2 mo. follow-up
| 1
| 41
| 1
|
58.68597
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 12
|
$11-$25k
| 0
| 18,292
| 8,339.8516
| 8,959.875
| 20
|
black
| 16.296875
| 10
| 0.735962
| 0.467957
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 6
| 57
| 44
| 125
| 35
| 36
| 233.3125
| null | null | 1
| 136
| 7.449219
| 415
| 34
| 1,870
| null | 0
|
no(M2 and SIP pres)
| 0
| 389
| 1
|
65.19598
|
male
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 18
|
>$50k
| 44
| null | 67,778.25
| 71,593.0625
| 34.666657
|
white
| 35.5
| 80
| 0.263977
| 0.15799
| 8
| 0
| 0
|
no
| 0.5
| 0.33
|
dnr after sadm
| 11
| 122
| 30.398438
| 125
| 12
| 36.59375
| 300
| null | null | 4
| 145
| 7.419922
| 95
| 119
| 694
| null | 1
|
<2 mo. follow-up
| 1
| 16
| 1
|
62.81998
|
male
| 0
| 19
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 62,304
| 31,476.3438
| 29,786.5938
| 18.666656
|
white
| 25.597656
| 23
| 0.799927
| 0.677979
| 1
| 1
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 19
| 67
| 25.398438
| 75
| 10
| 36.09375
| 375
| 4
| 7.799805
| 2.299805
| 133
| 7.349609
| 89
| 46
| 2,785
| null | 0
| null | 0
| 300
| 1
|
90.35699
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 5
|
$11-$25k
| 0
| 9,994
| 6,418.4141
| 4,934.63672
| 13
|
white
| 21.097656
| 30
| 0.751953
| 0.608887
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 6
| 66
| 10.5
| 38
| 24
| 35.29688
| null | 3.799805
| 1.799805
| 2
| 139
| null | 105
| 29
| 2,225
| 0
| null | null | 0.494751
| 542
| 0
|
58.98199
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 26
| 267,221
| 23,775.1719
| 22,595.0781
| 28.5
|
asian
| 25.097656
| 26
| 0.644897
| 0.544922
| 31
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 8
| 57
| 7.799805
| 105
| 12
| 36.59375
| 163.5
| 2.399902
| 36.398438
| 5.199219
| 135
| 7.109375
| 98
| 48
| 240
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 541
| 0
|
79.896
|
male
| 1
| 10
|
Coma
|
Coma
| 3
| null | null | 44
| 73,135
| 28,528.1875
| 32,434.875
| 29.5
|
white
| 25.5
| 63
| 0.297974
| 0.22699
| 1
| 0
| 1
|
no
| 0.1
| 0.05
|
dnr after sadm
| 1
| 127
| 18.699219
| 120
| 38
| 38.59375
| 208.15625
| null | null | 1.699951
| 130
| 7.489258
| null | 19
| 3,186
| null | null |
<2 mo. follow-up
| 5.791992
| 10
| 1
|
77.74396
|
female
| 1
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 18
|
under $11k
| 0
| 34,096
| 16,873.2656
| 15,810.1797
| 16
|
white
| 16.5
| 20
| 0.861938
| 0.770996
| 1
| 1
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 12
| 57
| 5.899414
| 135
| 22
| 36.89844
| null | 3.599609
| 0.799927
| 1.199951
| 134
| null | null | 25
| 3,120
| 5
| 5
|
<2 mo. follow-up
| 5
| 12
| 1
|
72.05194
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
under $11k
| 0
| 27,158
| 13,123.1953
| 12,970
| 26.5
|
hispanic
| 17.199219
| 26
| 0.870972
| 0.784912
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 9
| 57
| 7.099609
| 65
| 28
| 36.5
| null | null | 0.299988
| 1.199951
| 132
| null | null | 13
| 2,810
| null | null |
no(M2 and SIP pres)
| 3.253418
| 340
| 1
|
61.49799
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| 12
| null | 0
| 6,507
| 2,927.2148
| 4,986.19922
| 6
|
white
| 14.298828
| 15
| 0.765991
| 0.515991
| 1
| 1
| 0
|
metastatic
| 0.4
| 0.05
|
no dnr
| 4
| 97
| null | 110
| 22
| 37.89844
| null | null | null | null | 140
| null | 136
| null | 3,100
| 0
| 0
| null | 0
| 196
| 1
|
53.26797
|
female
| 1
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 309,174
| 109,134.188
| 104,876.375
| 38
|
white
| 28.898438
| 39
| 0.7229
| 0.637939
| 7
| 0
| 0
|
no
| null | null |
no dnr
| 21
| 55
| 27.597656
| 95
| 10
| 38.69531
| 267.5
| null | 13
| 3.699707
| 132
| 7.55957
| null | 61
| 0
| 0
| null |
<2 mo. follow-up
| 0.494751
| 21
| 1
|
67.16998
|
male
| 1
| 26
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 326,479
| 129,416.938
| 132,201.875
| 44.25
|
white
| 30.5
| 65
| 0.662964
| 0.565918
| 2
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 22
| 73
| 14.199219
| 55
| 24
| 36.5
| null | 2.599609
| 0.699951
| 1.599854
| 135
| null | 165
| 37
| 4,220
| null | null |
<2 mo. follow-up
| 2.918945
| 26
| 1
|
86.41998
|
male
| 1
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 9
| 88,769
| 34,941.5625
| 32,367.75
| 21.666656
|
white
| 42.796875
| 63
| 0.182983
| 0.094986
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 2
| 65
| 11.898438
| 124
| 52
| 39.39844
| null | null | null | 0.799927
| 136
| null | 116
| 22
| 1,425
| null | null |
<2 mo. follow-up
| 4.041992
| 16
| 1
|
48.76898
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 44
| 318,152
| 72,123.125
| 67,590.3125
| 31.25
|
white
| 23.796875
| 43
| 0.709961
| 0.621948
| 4
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 27
| 70
| null | 55
| 20
| 36
| null | null | null | 2
| 139
| null | 117
| 40
| 1,745
| null | 0
|
no(M2 and SIP pres)
| 0
| 534
| 0
|
41.12799
|
female
| 0
| 27
|
Coma
|
Coma
| 2
| 14
|
$25-$50k
| 44
| 141,917
| 56,199.0625
| 55,028.6875
| 27.75
|
white
| 31.5
| 45
| 0.516968
| 0.445984
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 22
| 107
| 1.899902
| 60
| 26
| 38
| 336.625
| 2.699707
| 0.699951
| 1.599854
| 133
| 7.459961
| 98
| 16
| 2,313
| null | 7
| null | 7
| 103
| 1
|
52.31998
|
male
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 16
|
>$50k
| 0
| 14,200
| 8,216.9844
| 8,403.46875
| 17
|
white
| 13.398438
| 18
| 0.935913
| 0.891968
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 63
| 7
| 75
| 40
| 38
| 67.76562
| 1.899902
| 0.599976
| 1.099854
| 132
| 7.519531
| 113
| 26
| 1,496
| null | null |
no(M2 and SIP pres)
| 2.151367
| 531
| 0
|
71.75397
|
male
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 18
| null | 26
| 198,019
| 80,928.8125
| 77,727.6875
| 28.75
|
white
| 28.296875
| 35
| 0.532959
| 0.417969
| 6
| 1
| 0
|
no
| 0.85
| 0.85
|
no dnr
| 38
| 71
| 8.099609
| 66
| 22
| 35.59375
| null | null | 0.799927
| 1
| 140
| null | 413
| 18
| 2,975
| null | 5
| null | 5
| 531
| 0
|
64.41595
|
female
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 10
|
$11-$25k
| 44
| 81,959
| 30,076.3281
| 30,402.0938
| 31
|
hispanic
| 19
| 24
| 0.737915
| 0.656982
| 3
| 0
| 0
|
no
| null | null |
dnr after sadm
| 10
| 65
| 10.798828
| 70
| 32
| 36.39844
| 376.1875
| null | null | 1.199951
| 140
| 7.399414
| 156
| 24
| 1,925
| null | 7
|
<2 mo. follow-up
| 7
| 13
| 1
|
56.66299
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 37
| 184,814
| 42,421.6875
| 40,814.5312
| 22
|
white
| 24.796875
| 19
| 0.650879
| 0.550903
| 8
| 0
| 0
|
no
| null | null |
no dnr
| 17
| 66
| 12.398438
| 64
| 22
| 36.39844
| null | 3.799805
| null | 0.799927
| 136
| null | 260
| 14
| 2,350
| null | null | null | 2.577637
| 529
| 0
|
20.73099
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 61
| null | 59,732.75
| 58,575.2812
| 28.333328
|
hispanic
| 29.597656
| 37
| 0.62793
| 0.524902
| 12
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 21
| 48
| 15.798828
| 100
| 24
| 38
| 273.3125
| null | null | 1.5
| 130
| 7.539062
| null | 24
| 1,745
| null | null |
no(M2 and SIP pres)
| 2.806641
| 528
| 0
|
77.31097
|
male
| 0
| 56
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 9
| 318,057
| 94,745.25
| 94,802.1875
| 26.25
|
black
| 26.597656
| 32
| 0.504883
| 0.387939
| 19
| 0
| 0
|
yes
| 0.85
| 0.8
|
no dnr
| 56
| 50
| 9.5
| 135
| 13
| 39.39844
| 196
| 1.599854
| 1.799805
| 0.899902
| 135
| 7.369141
| 236
| 21
| 1,800
| null | 0
|
no(M2 and SIP pres)
| 0
| 528
| 0
|
56.03299
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 18
|
$11-$25k
| 100
| 52,414
| 21,598.75
| 21,937.3594
| 34
|
white
| 40.398438
| 77
| 0.044998
| 0.014
| 2
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 78
| 12
| 115
| 36
| 36.79688
| 71.65625
| null | null | 3.899902
| 128
| 7.489258
| 145
| 73
| 2,350
| null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
76.42999
|
male
| 0
| 11
|
Lung Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| 29,862
| 14,500.4219
| 17,274.4688
| 15.5
|
white
| 16.296875
| 13
| 0.694946
| 0.405945
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.5
|
no dnr
| 11
| 70
| 14.699219
| 75
| 10
| 38.19531
| 212
| null | 1.599854
| 3.099609
| 152
| 7.519531
| 492
| 111
| 2,264
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 62
| 1
|
69.58795
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 16
| null | 0
| 9,532
| 4,846.543
| 4,340.04688
| 10
|
other
| 16.699219
| 6
| 0.703979
| 0.418945
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.6
|
no dnr
| 5
| 65
| 17.597656
| 165
| 26
| 38.39844
| 85
| null | null | 1
| 132
| 7.359375
| 253
| 18
| 1,440
| null | null | null | 2.340332
| 240
| 1
|
70.32996
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$25-$50k
| 37
| 65,043
| 28,584.9375
| 26,608.6719
| 21
|
white
| 24.199219
| 46
| 0.514893
| 0.397949
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 15
| 62
| 9.699219
| 65
| 20
| 36.19531
| null | 3.899902
| 0.599976
| 0.899902
| 139
| null | 124
| 18
| 1,660
| null | 1
|
<2 mo. follow-up
| 1
| 28
| 1
|
68.34497
|
female
| 0
| 16
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
>$50k
| 26
| 118,074
| 28,804.5938
| 27,936.1875
| 18.333328
|
white
| 22.5
| 32
| 0.660889
| 0.562988
| 20
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 16
| 85
| 20.296875
| 125
| 30
| 38.59375
| 315.5
| null | null | 2.899902
| 147
| 7.429688
| 101
| 68
| 2,545
| null | null | null | 2.81543
| 236
| 1
|
76.76099
|
male
| 0
| 24
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 16
|
$25-$50k
| 0
| 82,924
| 40,077.5312
| 37,836.375
| 24.333328
|
white
| 27.898438
| 34
| 0.692993
| 0.526978
| 1
| 0
| 0
|
no
| 0.78
| 0.68
|
no dnr
| 24
| 73
| 5.899414
| 75
| 10
| 38.29688
| 186
| null | null | 1.399902
| 152
| 7.339844
| null | 38
| 548
| 2
| 2
|
<2 mo. follow-up
| 2
| 28
| 1
|
58.823
|
female
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 14
|
$11-$25k
| 0
| 58,144
| 31,806.9531
| 33,860.8125
| 16.5
|
white
| 32.796875
| 31
| 0.691895
| 0.525879
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 12
| 98
| 19.5
| 115
| 29
| 38.69531
| 585
| null | 0.699951
| 0.599976
| 131
| 7.519531
| 172
| 12
| 3,055
| null | null | null | 3.062988
| 440
| 1
|
31.79999
|
female
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 12
|
under $11k
| 26
| 285,267
| 71,898.625
| 81,949.5
| 40
|
black
| 22.597656
| 57
| 0.819946
| 0.759888
| 12
| 1
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 21
| 115
| 14.699219
| 140
| 24
| 39.29688
| 402.5
| null | 5.299805
| 1.099854
| 128
| 7.459961
| 221
| 18
| 3,765
| null | 2
|
<2 mo. follow-up
| 2
| 24
| 1
|
55.32898
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
>$50k
| 0
| 39,435
| 17,091.9219
| 19,060.6094
| 25.5
|
white
| 22.398438
| 27
| 0.863892
| 0.774902
| 1
| 0
| 0
|
no
| 0.85
| 0.7
|
no dnr
| 11
| 82
| 20.199219
| 110
| 26
| 37.39844
| 137.5
| 2.299805
| null | 1.399902
| 140
| 7.429688
| 104
| 12
| 1,148
| 0
| 0
|
<2 mo. follow-up
| 0
| 38
| 1
|
55.35098
|
male
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 100
| 559,190
| 115,602.375
| 110,042.312
| 38.333313
|
white
| 36.5
| 74
| 0.054993
| 0.017998
| 21
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 24
| 65
| 12.099609
| 115
| 31
| 37.79688
| 220
| 2.699707
| 46.5
| 7.799805
| 138
| 7.5
| 184
| 96
| 328
| null | null | null | 3.620117
| 517
| 0
|
40.05197
|
female
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 14
| null | 0
| 26,709
| 12,503.6719
| 12,794.4844
| 15
|
asian
| 14.599609
| 15
| 0.881958
| 0.73291
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.2
|
no dnr
| 11
| 77
| 13.699219
| 80
| 20
| 36.59375
| null | null | null | 1.199951
| 134
| null | null | 14
| 2,900
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 515
| 1
|
33.043
|
male
| 0
| 62
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 11
|
$11-$25k
| 37
| 584,811
| 161,002.25
| 140,531.625
| 34.75
|
hispanic
| 31.296875
| 51
| 0.640991
| 0.539917
| 6
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 62
| 83
| 3
| 104
| 22
| 39.19531
| null | null | 0.799927
| 1.299805
| 138
| null | 144
| 15
| 2,750
| null | null |
no(M2 and SIP pres)
| 3.351074
| 515
| 0
|
75.20898
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
| null | 0
| 16,236
| 8,621.3047
| 6,855.44922
| 15.5
|
hispanic
| 21.796875
| 32
| 0.805908
| 0.68689
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 7
| 67
| 20.597656
| 55
| 25
| 36
| 371
| null | 0.299988
| 1.199951
| 129
| 7.609375
| 289
| 25
| 1,466
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 212
| 1
|
59.55099
|
male
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 49,137
| 22,125.8438
| 22,604.9062
| 13.5
|
white
| 18.199219
| 17
| 0.809937
| 0.746948
| 2
| 0
| 0
|
metastatic
| 0.2
| 0.04
|
dnr after sadm
| 1
| 68
| 13.699219
| 145
| 32
| 37.69531
| 344
| null | null | 0.799927
| 140
| 7.539062
| 133
| 14
| 2,183
| null | null |
<2 mo. follow-up
| 3.342285
| 8
| 1
|
65.30298
|
male
| 1
| 7
|
Coma
|
Coma
| 1
| 16
| null | 55
| 114,803
| 25,911.7031
| 28,150.0156
| 36.5
|
white
| 28.296875
| 51
| 0.200989
| 0.139984
| 13
| 1
| 0
|
no
| 0.1
| 0.1
|
dnr after sadm
| 7
| 46
| 8.099609
| 75
| 22
| 36.5
| null | 3.399902
| 2.099609
| 1.299805
| 130
| null | 108
| 35
| 3,113
| null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
34.31299
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 14
|
under $11k
| 37
| 109,897
| 21,670.1406
| 22,389.4375
| 18
|
white
| 44.195313
| 74
| 0.237
| 0.135986
| 17
| 0
| 0
|
no
| 0.2
| 0.05
|
dnr after sadm
| 1
| 49
| 5
| 55
| 22
| 35.79688
| null | null | null | 0.699951
| 124
| null | null | 25
| 3,550
| null | 1
|
<2 mo. follow-up
| 1
| 7
| 1
|
68.51495
|
female
| 0
| 28
|
Coma
|
Coma
| 0
| 16
| null | 61
| 269,996
| 97,231.25
| 87,709.5
| 39
|
white
| 25
| 25
| 0.276978
| 0.207977
| 4
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 28
| 60
| 25.597656
| 65
| 34
| 38.5
| 247.5
| null | 0.199982
| 5.599609
| 136
| 7.469727
| null | 79
| 0
| null | 0
|
Coma or Intub
| 0
| 163
| 1
|
70.56494
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| 20
| null | 0
| 13,976
| 7,062.5586
| 5,859.62891
| 19
|
white
| 16
| 32
| 0.714966
| 0.434998
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.7
|
no dnr
| 6
| 63
| 10.398438
| 75
| 16
| 36.29688
| null | 3.699707
| 2.399902
| 1.5
| 126
| null | 94
| 24
| 3,625
| null | null |
no(M2 and SIP pres)
| 2.323242
| 137
| 1
|
59.31
|
female
| 0
| 16
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4
| null | null | 9
| 45,458
| 22,102.3906
| 21,661.0781
| 16.333328
|
white
| 25.097656
| 26
| 0.672974
| 0.500977
| 1
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 16
| 132
| 2.399902
| 125
| 44
| 37.79688
| 182
| null | 1.199951
| 4.399414
| 140
| 7.339844
| 356
| 91
| 492
| null | null | null | 4.161133
| 131
| 1
|
35.17297
|
male
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 61
| 194,955
| 24,154.5312
| 24,888.5312
| 48
|
hispanic
| 21
| 21
| 0.430969
| 0.310974
| 40
| 0
| 0
|
yes
| 0.01
| 0
|
dnr after sadm
| 4
| 106
| 8.699219
| 76
| 14
| 37.5
| null | null | 0.299988
| 0.799927
| 132
| null | 85
| 11
| 1,800
| null | 0
|
<2 mo. follow-up
| 0
| 5
| 1
|
60.39999
|
male
| 0
| 7
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 10
| null | 0
| 81,201
| 10,525.8984
| 11,691.6562
| 15
|
white
| 18.796875
| 22
| 0.697998
| 0.60791
| 5
| 0
| 0
|
metastatic
| null | null |
no dnr
| 7
| 128
| 31.398438
| 125
| 25
| 39
| 192
| 2.5
| 6.099609
| 0.799927
| 151
| 7.439453
| 99
| 32
| 6,065
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 499
| 1
|
37.96298
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 13
|
$11-$25k
| 37
| 569,861
| 52,801.5938
| 52,417.7812
| 53
|
white
| 38.59375
| 74
| 0.362
| 0.243988
| 28
| 0
| 0
|
no
| 0.05
| 0.05
|
dnr after sadm
| 10
| 63
| 6.699219
| 105
| 20
| 36
| null | null | null | 1.899902
| 137
| null | null | 42
| 1,875
| null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
56.56097
|
male
| 0
| 48
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
>$50k
| 26
| 690,753
| 141,858.875
| 132,413.375
| 44.25
|
white
| 38.5
| 60
| 0.28595
| 0.176971
| 36
| 0
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 48
| 72
| 9.798828
| 72
| 28
| 36.39844
| null | null | null | 0.699951
| 136
| null | 159
| 7
| 3,625
| null | null | null | 2.624512
| 494
| 0
|
65.29999
|
female
| 0
| 4
|
Lung Cancer
|
Cancer
| 2
| null | null | 0
| 14,436
| 6,510.1836
| 8,984.05469
| 20
|
white
| 15.5
| 14
| 0.736938
| 0.468994
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 122
| 6.199219
| 145
| 8
| 38.89844
| 476.1875
| null | 2.899902
| 2.399902
| 130
| 7.569336
| null | 54
| 2,518
| null | null | null | 3.448731
| 494
| 0
|
84.08496
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 16
|
>$50k
| 0
| 29,939
| 17,392.6406
| 11,688.7031
| 8.5
|
white
| 19.398438
| 14
| 0.805908
| 0.685913
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 12
| 117
| 19.5
| 103
| 24
| 36.19531
| null | null | null | 1.899902
| 134
| null | 175
| 46
| null | null | 0
|
no(M2 and SIP pres)
| 0
| 493
| 0
|
71.05798
|
female
| 0
| 33
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 26
| 178,983
| 66,084
| 67,346
| 27.25
|
white
| 36.296875
| 58
| 0.250977
| 0.146973
| 3
| 0
| 0
|
yes
| 0.8
| 0.7
|
no dnr
| 33
| 115
| 1.599854
| 35
| 50
| 37.59375
| 72.5
| null | 5.199219
| 0.799927
| 137
| 7.419922
| 192
| 32
| 1,075
| null | 0
|
no(M2 and SIP pres)
| 0
| 373
| 1
|
36.33099
|
male
| 1
| 15
|
Coma
|
Coma
| 0
| null | null | 94
| 191,073
| 76,378.6875
| 77,532.0625
| 55.333313
|
white
| 34.296875
| 81
| 0.202972
| 0.141998
| 2
| 0
| 0
|
no
| 0.1
| 0.1
|
dnr after sadm
| 10
| 120
| 12.798828
| 125
| 30
| 39.19531
| null | null | 0.899902
| 0.699951
| 131
| null | 146
| 14
| 2,795
| null | null |
<2 mo. follow-up
| 2.785645
| 15
| 1
|
78.26996
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null |
under $11k
| 41
| 155,711
| 10,424.0391
| 10,553.8672
| 31
|
white
| 27.199219
| 47
| 0.312988
| 0.199982
| 20
| 1
| 0
|
yes
| 0.5
| 0.4
|
no dnr
| 6
| 73
| 0.199982
| 72
| 24
| 38.19531
| null | null | null | 0.599976
| 132
| null | null | 6
| 2,150
| null | 2
|
Coma or Intub
| 2
| 263
| 1
|
83.49597
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
| null | 26
| 174,489
| 53,113.5938
| 54,059.2188
| 30
|
white
| 27.199219
| 34
| 0.407959
| 0.28894
| 5
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 21
| 103
| 7.099609
| 67
| 24
| 36.09375
| 220
| null | 0.399963
| 1
| 140
| 7.359375
| 169
| 18
| null | null | null | null | 4.511719
| 491
| 0
|
48.58298
|
male
| 0
| 30
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 222,936
| 110,012.125
| 93,727.6875
| 34
|
white
| 22.898438
| 28
| 0.876953
| 0.795898
| 1
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 30
| 68
| 9.898438
| 98
| 24
| 36.19531
| null | 2.399902
| 7.399414
| 0.599976
| 143
| null | 103
| 3
| 3,800
| null | null | null | 3.19043
| 489
| 0
|
63.33499
|
male
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 43,200
| 20,651.7812
| 23,585.8906
| 11.5
|
white
| 16.199219
| 14
| 0.829956
| 0.630981
| 1
| 0
| 0
|
metastatic
| 1
| 0.5
|
no dnr
| 10
| 105
| 9.398438
| 50
| 26
| 39
| 480
| null | null | 0.699951
| 132
| 7.509766
| 271
| 10
| 2,570
| 0
| 1
| null | 1
| 467
| 1
|
34.53497
|
female
| 1
| 18
|
MOSF w/Malig
|
ARF/MOSF
| 3
| null | null | 44
| 437,598
| 107,912.312
| 95,340.5625
| 44
|
hispanic
| 41.5
| 93
| 0.032997
| 0.008999
| 28
| 0
| 0
|
yes
| 0.35
| 0.25
|
dnr after sadm
| 10
| 110
| 4.599609
| 62
| 24
| 36.79688
| null | null | null | 1.299805
| 138
| null | 366
| 33
| 4,400
| null | null |
<2 mo. follow-up
| 4.182617
| 18
| 1
|
53.69699
|
male
| 0
| 21
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 155,191
| 91,163.625
| 69,184.875
| 25.666656
|
white
| 16.597656
| 16
| 0.915894
| 0.85791
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 21
| 65
| 8.898438
| 125
| 10
| 38.39844
| 176
| 3.099609
| 32
| 4.799805
| 141
| 7.419922
| 178
| 61
| 12
| 0
| 0
| null | 0
| 488
| 0
|
46.89099
|
female
| 0
| 10
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| null |
$11-$25k
| 37
| 108,058
| 65,461.0312
| 45,364.6875
| 38.5
|
white
| 36.398438
| 56
| 0.526978
| 0.326965
| 1
| 0
| 0
|
no
| 0.95
| 0.93
|
no dnr
| 10
| 108
| 2.099609
| 135
| 26
| 38.29688
| 142
| null | 0.599976
| 5.799805
| 132
| 7.299805
| null | 50
| 1,045
| 1
| 0
| null | 0
| 489
| 0
|
66.89099
|
male
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 44
| 223,592
| null | null | 29
|
white
| 23.898438
| 38
| 0.570923
| 0.459961
| 12
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 22
| 107
| 18.097656
| 66
| 24
| 38
| null | null | null | 0.899902
| 136
| null | 170
| 6
| 1,175
| null | null | null | 3.091797
| 487
| 0
|
31.17599
|
female
| 1
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 11
|
$11-$25k
| 61
| 558,904
| 144,282.875
| 138,522
| 50.333313
|
hispanic
| 42.59375
| 95
| 0.181
| 0.093994
| 22
| 0
| 0
|
no
| 0.7
| 0.5
|
dnr after sadm
| 14
| 70
| null | 70
| 20
| 36.5
| 521.625
| null | 0.899902
| 1.799805
| 131
| 7.429688
| 157
| 19
| 2,050
| null | 7
|
<2 mo. follow-up
| 7
| 24
| 1
|
77.55499
|
female
| 0
| 25
|
Coma
|
Coma
| 2
| null | null | 44
| 168,806
| 38,366.5625
| 34,710.125
| 24.75
|
white
| 27.5
| 47
| 0.181
| 0.122986
| 7
| 1
| 0
|
no
| 0.4
| 0.3
|
dnr after sadm
| 4
| 43
| 14.898438
| 125
| 10
| 38
| 360
| 1.399902
| 0.599976
| 2.599609
| 133
| 7.319336
| 398
| 36
| 5,960
| null | 3
|
<2 mo. follow-up
| 3
| 33
| 1
|
36.70099
|
female
| 1
| 6
|
Coma
|
Coma
| 3
| 14
|
$11-$25k
| 100
| 139,607
| 32,443.6719
| 34,617.1875
| 50
|
white
| 47.398438
| 97
| 0
| 0
| 11
| 0
| 0
|
yes
| 0.2
| 0.2
|
no dnr
| 6
| 53
| 1.799805
| 125
| 30
| 34.79688
| 445.6875
| null | 0.299988
| 2.399902
| 134
| 7.389648
| 211
| 18
| 34
| null | null |
<2 mo. follow-up
| 3.439453
| 6
| 1
|
52.24899
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null |
$11-$25k
| 26
| 154,101
| 60,022.8125
| 59,715.5
| 26.5
|
white
| 21.898438
| 38
| 0.770996
| 0.696899
| 7
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 25
| 112
| 10.298828
| 120
| 40
| 35.89844
| 332
| null | null | 1.799805
| 138
| 7.469727
| null | 48
| 3,240
| null | 0
| null | 0
| 480
| 0
|
80.23499
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| null | null | 0
| 22,474
| 9,052.9141
| 10,659.0234
| 29
|
other
| 36.5
| 47
| 0.251953
| 0.14798
| 1
| 0
| 0
|
metastatic
| 0.1
| 0
|
no dnr
| 5
| 67
| 0.5
| 120
| 24
| 38.19531
| null | 2.399902
| 1.099854
| 1.199951
| 135
| null | 226
| 33
| 5,400
| null | null |
<2 mo. follow-up
| 3.253418
| 5
| 1
|
47.49298
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 2
| 12
|
>$50k
| 0
| 32,899
| 15,341.8359
| 19,223.4062
| 6.5
|
white
| 8.798828
| 7
| 0.917969
| 0.80896
| 1
| 0
| 0
|
metastatic
| 1
| 0.9
|
no dnr
| 7
| 62
| 12.5
| 65
| 29
| 37.89844
| 66.25
| null | null | 1.299805
| 142
| 7.489258
| 126
| 31
| 2,175
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 404
| 1
|
64.75
|
male
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 17
|
>$50k
| 0
| 161,773
| 34,648.2188
| 30,380.1719
| 23.333328
|
white
| 26.597656
| 38
| 0.622925
| 0.518921
| 20
| 0
| 0
|
yes
| 0.8
| 0.8
|
no dnr
| 18
| 70
| 9.099609
| 125
| 20
| 36.5
| null | null | null | 1.299805
| 130
| null | null | 26
| 4,940
| null | null | null | 3.260254
| 477
| 0
|
39.78098
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 0
| 87,541
| 17,153.9219
| 14,720.9297
| 19.5
|
white
| 27.398438
| 36
| 0.757935
| 0.681885
| 6
| 0
| 0
|
yes
| 0.95
| 0.95
|
no dnr
| 13
| 102
| 11.099609
| 80
| 24
| 36.39844
| null | null | 1.299805
| 1.199951
| 136
| null | 161
| 16
| 1,425
| 0
| null | null | 0.494751
| 476
| 0
|
79.70398
|
female
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 28,450
| 12,693.6328
| 14,254.0781
| 35
|
white
| 30.199219
| 50
| 0.625
| 0.439941
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 5
| 65
| 0.049995
| 145
| 12
| 36.19531
| 421.25
| 1.899902
| 5.599609
| 3.199707
| 148
| 7.5
| 374
| 90
| 1,356
| null | 0
|
no(M2 and SIP pres)
| 0
| 335
| 1
|
64.25696
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
under $11k
| 9
| 52,715
| 16,607.4531
| 15,969.4375
| 17
|
white
| 21.199219
| 28
| 0.802979
| 0.737915
| 3
| 1
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 8
| 62
| 7.399414
| 70
| 14
| 36.19531
| null | null | null | 1.5
| 137
| null | null | 13
| 2,095
| null | 0
|
no(M2 and SIP pres)
| 0
| 474
| 0
|
48.375
|
female
| 0
| 10
|
Lung Cancer
|
Cancer
| 1
| 19
|
>$50k
| 0
| 19,535
| 10,733.4609
| 11,613.3359
| 10
|
white
| 14.099609
| 11
| 0.791992
| 0.56189
| 1
| 0
| 0
|
metastatic
| 0.85
| 0.5
|
no dnr
| 10
| 48
| 15.898438
| 145
| 8
| 38.09375
| 130
| 3.299805
| 1.699951
| 0.799927
| 146
| 7.5
| 198
| 20
| 4,120
| 0
| null | null | 0.494751
| 106
| 1
|
52.293
|
male
| 0
| 11
|
Colon Cancer
|
Cancer
| 1
| 18
|
>$50k
| 0
| 24,621
| 12,094.4141
| 13,190.0625
| 14
|
white
| 11.599609
| 14
| 0.892944
| 0.755981
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.1
|
no dnr
| 11
| 140
| 12.099609
| 65
| 34
| 38.19531
| 159.15625
| 4.599609
| 1.599854
| 0.799927
| 132
| 7.419922
| 180
| 28
| 1,635
| 0
| 0
| null | 0
| 440
| 1
|
69.91595
|
male
| 0
| 28
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 37
| 269,095
| 69,369.1875
| 68,555.5625
| 37.5
|
white
| 32.59375
| 73
| 0.265991
| 0.159973
| 8
| 1
| 0
|
yes
| null | null |
no dnr
| 28
| 130
| 12.099609
| 145
| 26
| 39.39844
| 334
| 2.099609
| 34
| 2.599609
| 156
| 7.609375
| 648
| 96
| 1,775
| null | null | null | 3.459961
| 472
| 0
|
60.20499
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 26
| 189,109
| 46,810.6562
| 36,146.2812
| 25
|
asian
| 35.59375
| 64
| 0.265991
| 0.159973
| 25
| 0
| 0
|
yes
| 0.5
| 0.25
|
no dnr
| 17
| 72
| 19.597656
| 115
| 32
| 37.5
| 197.9375
| null | null | 1.699951
| 155
| 7.539062
| 468
| 69
| 2,455
| null | 0
|
no(M2 and SIP pres)
| 0
| 472
| 0
|
60.91699
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 16
|
under $11k
| 0
| 13,116
| 6,205.8125
| 6,476.56641
| 12
|
white
| 14.398438
| 11
| 0.763916
| 0.513916
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.4
|
no dnr
| 5
| 128
| 6.5
| 120
| 36
| 38.59375
| 127.5
| 2.299805
| 36
| 3
| 129
| 7.539062
| null | 69
| 213
| null | null |
no(M2 and SIP pres)
| 2.241699
| 254
| 1
|
53.75198
|
male
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 345,497
| 81,596.1875
| 86,074.3125
| 56
|
white
| 44
| 88
| 0.320984
| 0.20697
| 8
| 0
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 15
| 67
| 22.796875
| 130
| 10
| 37.89844
| 200
| null | 0.799927
| 0.899902
| 138
| 7.479492
| 227
| 16
| 1,245
| null | null |
<2 mo. follow-up
| 2.504395
| 15
| 1
|
30.53799
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 26
| 130,205
| 21,199.2188
| 23,719.5156
| 24
|
white
| 19.5
| 20
| 0.851929
| 0.800903
| 28
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 9
| 82
| 1.5
| 115
| 30
| 37.59375
| 176.1875
| null | null | 1
| 123
| 7.479492
| 173
| 26
| 1,700
| 1
| 1
| null | 1
| 468
| 0
|
73.84796
|
female
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 18
|
$11-$25k
| 44
| 77,209
| 27,299.3438
| 28,369.9688
| 34
|
hispanic
| 40.5
| 80
| 0.138977
| 0.064987
| 2
| 1
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 8
| 94
| 6.299805
| 106
| 24
| 36.59375
| null | 4.199219
| 0.5
| 1.099854
| 138
| null | 78
| 16
| 1,900
| null | null |
<2 mo. follow-up
| 4.28418
| 8
| 1
|
63.93399
|
female
| 1
| 10
|
Colon Cancer
|
Cancer
| 1
| 14
| null | 0
| 39,476
| 16,393.5781
| 17,796.2969
| 14.5
|
white
| 40
| 30
| 0.27594
| 0.040993
| 1
| 0
| 0
|
metastatic
| 0.5
| 0
|
dnr after sadm
| 8
| 131
| 6.299805
| 116
| 25
| 38.19531
| 197.125
| null | null | 2.299805
| 147
| 7.459961
| null | null | 5,658
| null | 6
|
<2 mo. follow-up
| 6
| 10
| 1
|
71.69299
|
female
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
|
$11-$25k
| 61
| 164,001
| 23,916.8125
| 24,213.8281
| 38.5
|
white
| 30.199219
| 47
| 0.247986
| 0.144989
| 29
| 0
| 0
|
no
| 0.1
| 0.1
|
dnr after sadm
| 2
| 137
| 11.898438
| 75
| 24
| 38.89844
| null | null | 1.399902
| 4.699219
| 126
| null | null | 90
| 5,200
| null | 5
|
<2 mo. follow-up
| 5
| 10
| 1
|
69.56897
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
| null | 0
| 35,691
| 16,373.8594
| 12,696.5859
| 16
|
black
| 21.796875
| 30
| 0.820923
| 0.708984
| 1
| 1
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 10
| 117
| 11.699219
| 175
| 16
| 36.09375
| 157.125
| null | null | 2.099609
| 138
| 7.269531
| 184
| 43
| 1,699
| 6
| 5
| null | 5
| 462
| 0
|
71.12396
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 44
| 227,604
| 49,044.9688
| 51,175.7188
| 45
|
black
| 42.296875
| 92
| 0.065994
| 0.022999
| 12
| 0
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 2
| 111
| 8
| 110
| 30
| 36.39844
| 197.5
| null | null | 0.799927
| 136
| 7.449219
| 265
| 14
| 1,150
| null | null |
<2 mo. follow-up
| 3.089844
| 12
| 1
|
65.52997
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 32,728
| 18,566
| 14,167.7578
| 15.5
|
black
| 16.699219
| 11
| 0.890991
| 0.817993
| 1
| 0
| 0
|
no
| 0.75
| 0.7
|
no dnr
| 13
| 75
| 8.898438
| 78
| 22
| 36.79688
| null | null | null | 0.799927
| 138
| null | null | null | 3,100
| 1
| 0
| null | 0
| 463
| 0
|
60.65997
|
female
| 0
| 16
|
Coma
|
Coma
| 1
| null | null | 9
| 59,110
| 27,980.5625
| 30,758.3438
| 12
|
hispanic
| 20.199219
| 15
| 0.637939
| 0.577881
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr before sadm
| -1
| 103
| 6.699219
| 78
| 22
| 38.5
| null | null | 0.5
| 1
| 140
| null | 86
| 11
| 1,050
| null | null |
<2 mo. follow-up
| 2.899414
| 51
| 1
|
75.16199
|
male
| 0
| 12
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 20
|
>$50k
| 0
| 43,004
| 18,532.2344
| 19,595.6094
| 26.5
|
white
| 13.898438
| 42
| 0.892944
| 0.819946
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 12
| 50
| null | 95
| 32
| 37.5
| 367.5
| 1.799805
| 10.199219
| 2.199707
| 142
| 7.439453
| 200
| 112
| 3,425
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 461
| 0
|
60.72299
|
male
| 1
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 44
| 165,860
| 56,255.9062
| 54,786.0312
| 38.666657
|
white
| 39.195313
| 73
| 0.219971
| 0.122986
| 4
| 0
| 0
|
no
| 0.75
| 0.7
|
dnr after sadm
| 11
| 143
| 0.049995
| 135
| 36
| 35.5
| 540
| 3
| null | 1.5
| 135
| 7.55957
| null | 29
| 2,480
| null | null |
<2 mo. follow-up
| 3.604492
| 15
| 1
|
54.67499
|
male
| 0
| 10
|
Colon Cancer
|
Cancer
| 1
| 16
|
>$50k
| 0
| 32,539
| 14,322.4609
| 17,685.9688
| 14.5
|
white
| 25.296875
| 5
| 0.701904
| 0.415955
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 10
| 73
| 5.199219
| 76
| 24
| 36.39844
| null | null | null | 1.099854
| 136
| null | null | 3
| 2,400
| null | null | null | 2.959473
| 250
| 1
|
56.00299
|
male
| 0
| 24
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 10
| null | 0
| 130,715
| 66,234.25
| 43,036.0625
| 18.666656
|
white
| 21
| 22
| 0.876953
| 0.794922
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 24
| 68
| 46.5
| 150
| 40
| 39.29688
| 130
| 3
| 16.097656
| 2.299805
| 150
| 7.539062
| 300
| 63
| 2,420
| 0
| 0
| null | 0
| 460
| 0
|
58.54599
|
female
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 11,516
| 7,043.5547
| 5,208.17969
| 12
|
white
| 18.5
| 24
| 0.86499
| 0.776978
| 1
| 1
| 0
|
yes
| 1
| 0.7
|
no dnr
| 6
| 72
| 7.799805
| 135
| 10
| 36.69531
| 391.8125
| null | 0.399963
| 0.699951
| 136
| 7.519531
| 103
| 7
| 5,660
| null | null | null | 3.390137
| 460
| 0
|
78.27496
|
female
| 1
| 7
|
Coma
|
Coma
| 0
| null | null | 37
| 63,413
| 19,578.7656
| 22,750.2344
| 38
|
asian
| 35.695313
| 38
| 0.043999
| 0.021999
| 8
| 0
| 0
|
no
| 0.2
| 0.5
|
no dnr
| 7
| 52
| 12.898438
| 120
| 40
| 39.79688
| 148.875
| 3.399902
| null | 3.599609
| 143
| 7.459961
| null | 87
| 73
| null | null |
<2 mo. follow-up
| 2.394531
| 7
| 1
|
79.07495
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 12
|
under $11k
| 0
| 14,921
| 9,544.6016
| 7,000.54688
| 18.5
|
white
| 20
| 34
| 0.771973
| 0.636963
| 1
| 1
| 0
|
yes
| 0.6
| 0.4
|
dnr before sadm
| -1
| 69
| 9.699219
| 120
| 16
| 36.79688
| null | 1.799805
| null | 0.599976
| 140
| null | null | 16
| null | null | 3
|
no(M2 and SIP pres)
| 3
| 183
| 1
|
71.146
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 19
|
>$50k
| 0
| 8,208
| 4,140.8594
| 3,448.91992
| 15
|
white
| 20.5
| 35
| 0.836914
| 0.73291
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 3
| 52
| 22.296875
| 125
| 24
| 36.19531
| null | 3.099609
| null | 1.799805
| 138
| null | null | 47
| 1,925
| null | null |
no(M2 and SIP pres)
| 2.431152
| 402
| 1
|
47.20898
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 120,554
| 50,712.9062
| 49,997.125
| 21
|
white
| 27.796875
| 24
| 0.827881
| 0.718994
| 1
| 0
| 0
|
no
| 0.95
| 0.92
|
no dnr
| 16
| 163
| 17
| 116
| 22
| 36
| 300
| null | null | 1.199951
| 139
| 7.379883
| 282
| 26
| 1,925
| null | 0
| null | 0
| 458
| 0
|
52.97198
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 9
|
$25-$50k
| 0
| 109,462
| 9,459.1641
| 15,796.4297
| 36
|
white
| 26.597656
| 27
| 0.761963
| 0.621948
| 18
| 0
| 0
|
no
| 0.7
| 0.55
|
no dnr
| 5
| 52
| 44.5
| 150
| 14
| 38.29688
| 225.4375
| 3
| 25.796875
| 4.899414
| 142
| 7.419922
| 94
| 76
| 28
| null | 3
|
SIP>=30
| 3
| 74
| 1
|
59.28299
|
female
| 1
| 31
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 41
| 263,478
| 96,814.8125
| 83,578.5
| 26.75
|
black
| 29.597656
| 47
| 0.309998
| 0.196991
| 4
| 0
| 0
|
yes
| 0.6
| 0.6
|
dnr after sadm
| 26
| 105
| 6.199219
| 105
| 24
| 36.79688
| null | null | null | 1.099854
| 139
| null | 92
| 14
| 4,950
| null | 5
|
<2 mo. follow-up
| 5
| 31
| 1
|
66.92096
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 100
| 259,419
| 10,136.9922
| 9,748.00781
| 29
|
hispanic
| 81.6875
| 116
| 0
| 0
| 41
| 1
| 0
|
no
| 0.2
| 0.2
|
no dnr
| 3
| 103
| 20.199219
| 105
| 20
| 36.79688
| null | null | null | 0.699951
| 141
| null | 172
| 9
| 1,750
| null | 0
|
<2 mo. follow-up
| 0
| 3
| 1
|
44.89297
|
female
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 12
|
>$50k
| 0
| null | 6,676.3672
| 7,199.01953
| 10
|
white
| 9.5
| 14
| 0.915894
| 0.803955
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.3
|
no dnr
| 7
| 55
| 12.798828
| 75
| 12
| 38.29688
| null | 3.399902
| 0.899902
| 1.699951
| 138
| null | 128
| 30
| 1,920
| 0
| null | null | 0.494751
| 174
| 1
|
52.323
|
male
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
$11-$25k
| 0
| 108,450
| 65,760.8125
| 49,937.4688
| 34
|
white
| 26.097656
| 40
| 0.830933
| 0.723999
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 13
| 55
| 11.298828
| 35
| 10
| 35
| 262.5
| 1.899902
| 20.5
| 1.699951
| 138
| 7.40918
| 229
| 55
| 2,211
| null | null |
no(M2 and SIP pres)
| 3.303711
| 454
| 0
|
41.60699
|
female
| 1
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 41
| 590,617
| 62,744.5312
| 57,986.75
| 37.5
|
hispanic
| 43.695313
| 84
| 0.185974
| 0.096985
| 15
| 0
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 12
| 83
| 10.898438
| 76
| 16
| 36.59375
| null | 2.599609
| 1
| 0.899902
| 137
| null | 100
| 11
| 2,840
| null | null |
<2 mo. follow-up
| 2.734375
| 13
| 1
|
53.50299
|
male
| 0
| 17
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 14
|
>$50k
| 0
| 150,298
| 90,096
| 65,634.875
| 30.333328
|
white
| 21.5
| 31
| 0.876953
| 0.795898
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 17
| 63
| 12.699219
| 125
| 26
| 39.09375
| null | 3.699707
| 1.299805
| 1.299805
| 138
| null | 154
| 14
| 2,670
| 0
| 0
| null | 0
| 453
| 0
|
73.24799
|
male
| 0
| 7
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 18
| null | 9
| 12,039
| 6,354.4219
| 6,221.9375
| 8
|
white
| 25.699219
| 45
| 0.531982
| 0.332947
| 1
| 0
| 0
|
no
| 0.3
| 0.3
|
dnr after sadm
| 2
| 107
| 6.899414
| 75
| 20
| 36
| null | null | null | 1.899902
| 142
| null | 167
| 40
| 2,850
| null | null |
<2 mo. follow-up
| 2.677246
| 24
| 1
|
74.17395
|
female
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 322,777
| 102,572.188
| 107,645.438
| 40
|
white
| 28.597656
| 54
| 0.621948
| 0.517944
| 7
| 1
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 22
| 42
| 23.398438
| 105
| 10
| 36.29688
| 316
| null | null | 2
| 135
| 7.25
| null | 40
| 2,650
| null | null |
<2 mo. follow-up
| 2.542969
| 23
| 1
|
57.49799
|
male
| 1
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 17
|
>$50k
| 26
| 347,324
| null | null | 36
|
white
| 40.796875
| 58
| 0.22699
| 0.127991
| 21
| 0
| 0
|
no
| 0.2
| 0.05
|
dnr after sadm
| 6
| 70
| 6.199219
| 70
| 20
| 36.5
| null | null | null | 2.799805
| 139
| null | null | 59
| 1,175
| null | 0
|
<2 mo. follow-up
| 0
| 9
| 1
|
72.20294
|
male
| 0
| 9
|
Lung Cancer
|
Cancer
| 1
| 18
|
$11-$25k
| 0
| 38,812
| 18,041.3594
| 19,459.875
| 9.5
|
white
| 20.398438
| 23
| 0.61499
| 0.29895
| 1
| 0
| 0
|
metastatic
| 0.65
| 0.4
|
no dnr
| 9
| 72
| 6.399414
| 75
| 22
| 37
| null | null | null | 2.399902
| 131
| null | 153
| 77
| 600
| null | null |
no(M2 and SIP pres)
| 3.495117
| 146
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.